David H Lindner DO MBA FCCP FACOI

Critical Care Medicine, Pulmonary Vascular Medicine

Medical Director COVID19, Medical Director ICU/Respiratory Care

Summary

David Lindner, DO, is a pulmonologist based in Naples, FL, with subspecialties in Critical Care Medicine and Pulmonary Vascular Medicine. He completed his medical education at Des Moines University College of Osteopathic Medicine in 1989 and a fellowship in Pulmonary Disease and Critical Care Medicine at SSM Health/Saint Louis University School of Medicine. Additionally, he earned an MBA in Medical Administration from Auburn University. His clinical experience includes interventional pulmonology, sarcoidosis, pulmonary arterial hypertension, mycobacterial infections, and critical care medicine. Dr. Lindner has published several articles in medical journals and conferences, one of which is cited multiple times. He has been recognized as Physician of the Year by NCH Healthcare in 2020 and was a Physician of the Year Honoree in 2008.

Auburn UniversityMBA, Medical Administration , Magma Cum Lada, 2009 - 2010
SSM Health/Saint Louis University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1995
Des Moines University College of Osteopathic MedicineClass of 1989

Physician of the year NCH Healthcare, 2020
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2012, 2014, 2016-2017

PubMed

1 citations
Sarcoid-like reaction in malignant melanoma exacerbated with pembrolizumab therapy case report.
Mohammed Ahsan, Alex Ashkin, David H Lindner, Vishal P Patel, Andrew Lipman
Heliyon. 2024-01-30
3 citations
Fibrosing mediastinitis resulting in unilateral pulmonary artery hypertension.
Zackary Anderson, Alex Ashkin, Noelle Messina, Carl Ruthman, David Lindner
Respiratory Medicine Case Reports. 2024-01-01
Spontaneous Pneumomediastinum, Pneumoperitoneum, and Subcutaneous Emphysema beyond the Inguinal Ligament Secondary to Inversion Maneuvers.
Keegan Plowman, David Lindner, Jose Ruben Valle-Giler
Case Reports in Pulmonology. 2022-01-01

Journal Articles

Procalcitonin and COVID-19: A Reliable Diagnostic Tool
J Bass, D Lindner, https://mc.manuscriptcentral.com/emj, 2020

Books/Book Chapters

Critical Care
Chapter: Cerebral Resuscitation
D. Lindner, C. VeramakisEditors: J. Civetta, R. Taylor, T. Kirby.J.B. Lippinocott Company Edition 3rd,1995

Abstracts/Posters

Bilateral Pneumothorax Resolved with a Single Chest Tube:
S. Patel, D. Lindner, ATS International Conference 2022: # 5098
What an Actor: Endobronchial Actinomyces Masquerading as Carcinoid Tumor
C. Williams, D. Lindner, ATS International Conference 2022: # 3998, 5/2022
Angio-Vac Extraction of a Free-Floating Right Heart April,2022 Thrombus-In-Transit
S. Patel, D. Lindner, ACC22 #8501, 4/2022

NCH Is First in Florida Selected for National ALIYA PEF Galvanize Clinical TrialOctober 15th, 2025
NCH Achieves #2 Ranking in Florida for ION Robotic-Assisted Lung Biopsy ProceduresSeptember 25th, 2025
New NCH Technology to Destroy TumorsJanuary 21st, 2025

Co-InvestigatorEdwards PASCAL TrAnScatheter Valve RePair System (CLASP II Tr)”2022 - Present
Principal Investigator“Prevalence of Sleep-Disordered Breathing In Patients Undergoing Transcatheter Aortic Valve Repair: A Single-Center Observational Study.”2021 - Present
Co-InvestigatorReduce LAP RCT II Elevated Left Atrial Pressure in Patients with Heart Failure2020 - Present
Principal InvestigatorOSA: T90/T89 and Pulmonary Arterial Hypertension 2019 (hypoxic challenge) Pilot Proof of Concept Study,2019 - 2022
Principal InvestigatorAssociation of Procalcitonin and COVID19 Retrospective observational laboratory study COVID19 BioMerieux Rapid PCR for SARS-CoV-2 Coronovirus.2020 - 2021